CRISPR Therapeutics AG (CRSP): Price and Financial Metrics

CRISPR Therapeutics AG (CRSP): $40.60

0.98 (+2.47%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add CRSP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#307 of 336

in industry

CRSP Price/Volume Stats

Current price $40.60 52-week high $91.10
Prev. close $39.62 52-week low $36.52
Day low $40.60 Volume 70,076
Day high $40.60 Avg. volume 1,871,992
50-day MA $42.94 Dividend yield N/A
200-day MA $49.59 Market Cap 3.47B

CRSP Stock Price Chart Interactive Chart >


CRISPR Therapeutics AG (CRSP) Company Bio


CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.


CRSP Latest News Stream


Event/Time News Detail
Loading, please wait...

CRSP Latest Social Stream


Loading social stream, please wait...

View Full CRSP Social Stream

CRSP Price Returns

1-mo 4.50%
3-mo -13.34%
6-mo -15.15%
1-year -44.22%
3-year -31.65%
5-year -27.24%
YTD 3.15%
2024 -37.12%
2023 54.00%
2022 -46.36%
2021 -50.51%
2020 151.39%

Continue Researching CRSP

Here are a few links from around the web to help you further your research on CRISPR Therapeutics AG's stock as an investment opportunity:

CRISPR Therapeutics AG (CRSP) Stock Price | Nasdaq
CRISPR Therapeutics AG (CRSP) Stock Quote, History and News - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!